Josh Riggs serves as Executive at Oncocyte Corp, where they oversee executive responsibilities. Since joining the company, Josh Riggs has executed 1 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 11, 2024 involved purchasing 3,390 shares valued at $10.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 11, 2024 | OCX | $10.0K | Purchase | 3,390 | $2.95 | Discretionary |
Josh Riggs currently holds 3,505 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Josh Riggs has been a net buyer of OCX stock. They have purchased $10.0K and sold $0 worth of shares.
Josh Riggs's most recent insider trade was on Apr 11, 2024, when they purchased 3,390 shares at $2.95 per share.
Get notified when new Form 4 filings are submitted